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Summary
Objective: To investigate the effects of increasing extracellular osmolality on aggrecan gene expression and cell size in cultured
chondrocytes.
Design: Aggrecan promoter activity and mRNA levels were measured in bovine monolayer chondrocytes subjected to hyperosmotic loading
for different time periods, using transient transfection assays or RT-PCR. Cell size changes were also determined using an epifluorescence
microscopy system.
Results: Hyperosmotic loading for 24 h suppressed aggrecan promoter activity and mRNA levels approximately two-fold. However no
suppression of promoter activity was observed when exon 1 was deleted from the human aggrecan promoter construct. Osmotic regulation
of aggrecan gene expression was time-dependent and found to correlate with cell shrinking and swelling. No suppression in promoter activity
was observed when the hyperosmotic stimulus was applied in a cyclic manner, or when serum was present in the culture medium.
Conclusion: Hyperosmotic loading regulates aggrecan gene expression and cell size in isolated chondrocytes. Osmotic regulation of gene
expression is also affected by the time-varying nature of loading and the presence of serum. © 2001 OsteoArthritis Research Society
International
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The unique load-bearing properties of articular cartilage
depend on the structural composition and ultrastructural
organization of the specialized connective tissue, particu-
larly the interaction between collagens and proteoglycans
of the extracellular matrix (ECM)1,2. Aggrecan is the large
aggregating proteoglycan of articular cartilage and each
aggrecan molecule contains over a hundred highly sul-
fated, negatively charged glycosaminoglycan (GAG) chains
covalently attached to its protein core. The functional
properties of aggrecan reside in its ability to concentrate
negative charges, giving rise to the tissue’s highly negative
fixed charge density (FCD), as well as form macromolecu-
lar aggregates with hyaluronan3,4. Articular cartilage thus
contains high cation concentrations and tissue osmolality
relative to other body fluids, ∼380/450 mOsm/kgH2O5. Joint
loading of articular cartilage leads to matrix deformation761and fluid flow within the soft hydrated tissue. The combina-
tion of fluid flow and deformation-induced changes in FCD
expose chondrocytes to osmotic changes in their milieu.
These osmotic variations represent one important physical
stimulus in the regulation of chondrocyte activities6.
The synthesis, incorporation and degradation of ECM
proteins is orchestrated by chondrocytes which are in turn
regulated by environmental factors. It has been well estab-
lished that mechanical forces can regulate the metabolic
activity of chondrocytes in articular cartilage (see Guilak
et al.7 for a comprehensive review). In vivo studies using
animal models for joint disuse or surgically-induced joint
instability have shown that altered mechanical loading
results in cartilage pathology. Changes in aggrecan
synthesis8–11 and increased aggrecan degradation8–11
have been identified as important events in these models.
Re-establishing the mechanical environment by joint remo-
bilization in the disuse model reverses the suppression of
aggrecan synthesis and restores the mechanical properties
of cartilage12. A number of in vitro studies have been
performed to investigate how mechanical signals control
aggrecan expression and synthesis. Deformational loading
studies using cartilage explants demonstrate that long-term
static compression of cartilage suppresses aggrecan syn-
thesis13,14 while short-term cyclic compression at specific
frequencies can stimulate aggrecan synthesis14–16. Mech-
anical loading of articular cartilage also generates a com-
plex series of physical events at the tissue and cellular
level which could potentially modulate chondrocyte bio-
synthetic activity6. Studies have shown that hydrostatic
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can synthesis but their interaction in determining the overall
cellular response remains unclear.
Static loading of articular cartilage also causes fluid
expression and increased proteoglycan concentration sur-
rounding the chondrocyte which leads to alterations in ionic
and osmotic composition of the tissue. Changes in extra-
cellular osmolality have also been shown to affect chondro-
cyte biosynthetic activities5,22–25. Urban et al.25 reported
maximal proteoglycan and protein synthetic rates at physi-
ologic osmolarity (350–450 mOsm) in cartilage and iso-
lated chondrocytes. Increasing or decreasing the media
osmolality outside this range (by different amounts of
sucrose or NaCl addition) led to a fall in proteoglycan
synthesis rates. Chondrocyte swelling and shrinkage have
also been reported in cartilage and isolated cells in
response to hypo- and hypertonic shock22,26,27. Since cell
shape is known to influence chondrocyte phenotypic
expression28, cell deformation due to osmotic swelling and
shrinkage may be a potential mechanism through which
proteoglycan synthesis is regulated in response to osmotic
loading. Alterations in intracellular ionic composition have
also been suggested to be responsible for the fall in
proteoglycan synthesis rates25. This is supported by the
observed stimulation of ion transporters such as the Na+-
K+-2Cl−29 cotransporter and the Na+/H+ exchanger30 in
response to increased osmolality and cell shrinkage.
Despite these findings, the molecular mechanisms
involved in osmotic regulation of aggrecan synthesis are
not known. Previous in vitro studies have demonstrated
regulation of aggrecan mRNA levels in response to
a number of physical stimuli including static
compression31–33 and hydrostatic pressure17,18. We have
previously demonstrated that fluid-flow induced shear-
stress of bovine articular chondrocytes down-regulates
aggrecan gene expression at the level of promoter activity
using a reporter construct containing a 2.4 kb promoter
fragment and exon 1 of the human aggrecan gene19.
Analysis of this portion of the gene has revealed several
putative mechanoresponsive elements (SSREs)33 which
may mediate transcriptional regulation in response to
fluid-flow and other physical stimuli. In this study we
hypothesize that this region of the aggrecan gene is simi-
larly involved in the regulation of aggrecan gene expression
in response to osmotic loading of isolated chondrocytes.
We also investigated the correlation between aggrecan
gene expression and chondrocyte cell size in response to
osmotic changes. A better understanding of the molecular
mechanisms involved in osmotic regulation of aggrecan
gene expression may help elucidate the mechanisms that
underlie chondrocyte mechanotransduction.Methods
PREPARATION OF HUMAN AGGRECAN PROMOTER CONSTRUCTS
A 1.7-kb fragment, corresponding to the distal portion of
the human aggrecan promoter, was cloned into the MluI/
NdeI site of a luciferase reporter construct pAGC1(−701)/
5UTR19, which contained the proximal 701-bp promoter
region and exon 1 (5′-UTR). This generated the construct
pAGC1(−2368)/5UTR. A second promoter construct
containing a deletion in exon 1 was made by digesting
pAGC1(−2368)/5UTR with PpuM1 to generate pAGC1(−
2368/+25) (Fig. 1).CELL CULTURE
Bovine articular cartilage was harvested from the carpo-
metacarpal joint of 4- to 6-month-old calves within 6 h of
sacrifice and enzymatically digested with hyaluronidase
and collagenase, as previously described19, to isolate
chondrocytes. Chondrocytes were plated at a density of
5×105 cells per 35 mm dish. The cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum, amino acids (0.5×
minimum essential amino acids, 1× non-essential amino
acids), buffering agents (10 mM Hepes, 10 mM TES, 10
mM BES) and antibiotics (100 units/ml penicillin, 100 g/ml
streptomycin) in a 5% CO2 incubator at 37°C until exper-
iments. The osmolality of this medium was measured
using a freezing point depression osmometer (Advanced
Instruments Inc, Norwood, MA) and determined to be
360 mOsm. Similar to reports by other investigators28,
cultured chondrocytes in our study exhibited positive type II
collagen staining and cuboidal morphology, in addition
to exhibiting aggrecan gene expression, throughout the
duration of our investigations.TRANSIENT TRANSFECTION
Primary chondrocytes were transiently transfected with
3 g of aggrecan promoter construct and 0.75 g of -gal
cotransfection plasmid per 35 mm dish, 24 h after plating,
using the ProFection calcium phosphate mammalian trans-
fection kit (Promega Corporation, Madison, WI). After trans-
fection for 48 h, cells were lysed and luciferase and
-galactosidase activities were determined as previously
described19.QUANTITATION OF mRNA LEVELS
For RNA quantitation, total RNA was extracted from
untransfected chondrocytes, 72 h after plating, using the
RNAgents Total RNA isolation system (Promega), which is
based on the method of Chomczynski and Sacchi34. The
isolated RNA was further purified using the RNeasy Kit
(Qiagen Inc., Valencia, CA), and the levels of aggrecan
mRNA were quantified as previously described33,35.–2368 pAGC1(–2368)/5UTRLUC
–2368 pAGC1(–2368/+25)LUC
+25
Fig. 1. Schematic of human aggrecan promoter constructs used in
transfection studies. A construct containing a 2368-bp promoter
fragment and exon 1 of the human aggrecan gene was made by
cloning a 1.7-kb upstream promoter fragment into the previously
made pAGC1(−701)/5UTR33. This pAGC1(−2368)/5UTR con-
struct was used as a template to generate an exon 1 deletion
construct, pAGC1(−2368/+25), which had 350 nucleotides
removed from the end of exon 1.OSMOTIC LOADING
Isolated chondrocytes were incubated with solutions of
different osmolality for various time points in a 37°C, 5%
CO2 incubator. The solutions were prepared by adding
increasing amounts of sucrose, NaCl or polyethylene glycol
Osteoarthritis and Cartilage Vol. 9, No. 8 763(PEG) to fully supplemented DMEM without serum. The
osmolality of this medium was also 360 mOsm. The osmo-
lality was then adjusted from standard DMEM to give a
range of 360 mOsm to 680 mOsm by solute addition.
Studies were performed with sucrose as the solute unless
otherwise stated. After osmotic loading either aggrecan
promoter activity, mRNA levels or cell size measurements
were determined.CELL SIZE MEASUREMENTS
In order to determine the effect of osmolality on cell size,
digital images of chondrocytes subjected to osmotic shock
were recorded using an epifluorescence microscopy sys-
tem. The system consisted of an Olympus 1X −70 inverted
microscope, and a MicroMax 5-Mhz interline transfer chip
camera (Princeton Instruments, Trenton, NJ). Hoffman
modulation contrast images were recorded using a 10×
objective (0.683 pixel/m) and MetaMorph software
(Universal Imaging Corporation, NJ). Monolayer cells were
then placed under the microscope 48 h after plating and
subjected to osmotic shock. For static (continuous) osmotic
loading digital images were recorded at regular time inter-
vals up to 24 h. For dynamic loading, images were acquired
every 5 min. Using 400× digital magnification, cell borders
were manually outlined for at least 10 cells (loaded and
control) using MetaMorph software. The precision of this
measurement was determined to be ∼1.4%. The cell area
of each cell over time (t) was normalized by its original cellarea (t=0). The cell area ratios for hyperosmotically loaded
cells (over time) were then normalized to the mean cell
area ratio (over time) of isotonic controls.STATISTICAL ANALYSIS
Comparisons were performed on all data using either
paired or unpaired t-test, one sample t-test, or one way
analysis of variance (ANOVA) with the Student–Newman–
Keuls multiple range comparison test with =0.05. For cell
size comparisons, statistical analysis was performed on
raw data for 0–10 min groups whereas normalized data
was compared for t>10 min groups.Results0.7
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Fig. 2. The effect of hyperosmotic loading on chondrocyte cell size. Images of cells were recorded and cell borders were manually outlined
for 10 cells (1–10 min) or 55 cells (1–24 h) at each time point using MetaMorph software. Representative Hoffman modulation contrast
images for t=0 and t=24 h are shown. Cell areas for each time point were normalized to their initial size at t=0. The values for
hyperosmotically loaded cells (580 mOsm) are expressed relative to isotonic controls (360 mOsm) for each time point. *Indicates significant
difference relative to initial cell size at t=0.EFFECT OF OSMOTIC LOADING ON CHONDROCYTE CELL SIZE
To investigate the effect of medium osmolality change on
cell size, the cell size of cultured chondrocytes exposed to
hyperosmotic (580 mOsm) media was measured over a
period of 24 h (Fig. 2). Exposure to hyperosmotic media
decreased average chondrocyte cell size by 5–20% over
the first 10 min (P<0.0001 to P=0.011, N=10–55), but
within 1 h cell size recovered significantly (P<0.0001 rela-
tive to 10 min, N=55) to its original size. However, no
further recovery was observed after 1 h and average cell
size remained decreased by 12–13% compared to initial
764 G. D. Palmer et al.: Osmotic regulation of aggrecan gene expressionsize (P<0.0001). The same cell size changes were
observed with hyperosmotic media made by NaCl addition
instead of sucrose (data not shown). Although direct
measurements of osmotic loading-induced cell volume
changes were not performed, a positive correlation
between change in cell area and change in peak cell height
(Pearson correlation coefficient r=0.53, P=0.03, N=16)
was determined using confocal microscopy of represen-
tative cells. Relative changes to peak cell height were
greater than changes to cell area.OSMOTIC LOADING REGULATES AGGRECAN GENE EXPRESSION
Previous studies have demonstrated that osmolality
regulates proteoglycan synthesis rates in isolated chondro-
cytes25. To determine if osmolality regulates aggrecan
gene expression directly, aggrecan promoter activity and
mRNA levels were measured in cultured chondrocytes after
incubation with hyper-osmotic media for 24 h.
To investigate aggrecan promoter activity, chondrocytes
were transfected with a chimeric luciferase reporter con-
struct, pAGC1(−2368)5UTR, containing 2.4 kb of the
human aggrecan promoter and exon 1 (5′-UTR). Hyper-
osmotic loading with 580 and 680 mOsm media signifi-
cantly decreased activity of pAGC1(−2368)/5UTR by
60–70% (P<0.0001) [Fig. 3(A)]. The effect of osmotic
loading on aggrecan promoter activity was also tested
using a second reporter construct, pAGC1(−2368/+25),
which contained a truncated exon 1 (5′-UTR). This portion
of the aggrecan gene has previously been shown to contain
important regulatory regions that modulate basal and
regulated promoter expression19,33,36. In contrast to
pAGC1(−2368)/5UTR, hyperosmotic loading with either
580 or 680 mOsm media did not significantly change
activity of pAGC1(−2368/+25) relative to control cultures
[Fig. 3(A)].
The effect of hyperosmotic loading on pAGC1(−2368)/
5UTR activity was also investigated using growth media
containing NaCl and PEG [Fig. 3(B)]. Adjusting the media
osmolality to 580 mOsm by PEG or NaCl addition had
similar effects to sucrose, causing a significant 50–60%
suppression of pAGC1(−2368)/5UTR activity.EFFECT OF OSMOLALITY ON AGGRECAN mRNA LEVELS
To determine if osmolality also regulates aggrecan
steady-state mRNA levels, quantitative PCR was per-
formed on RNA extracted from chondrocytes cultured in
hyperosmotic (580 mOsm) media for 24 h. Hyperosmotic
loading suppressed aggrecan mRNA levels compared with
360 mOsm controls [Fig. 3(C)], but the magnitude of sup-
pression was approximately 15% lower than promoter
activity. The observed suppression of aggrecan mRNA
levels is consistent with our aggrecan promoter studies.0
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Fig. 3. (A) The effect of hyperosmotic loading on activity of the
human aggrecan promoter. Primary monolayer chondrocytes were
transiently transfected with an aggrecan promoter-luciferase con-
structs, pAGC1(−2368)/5UTR or pAGC1(−2368/+25). After trans-
fection, cells were incubated with DMEM or hyperosmotic DMEM
prepared by addition of increasing amounts of sucrose. In all
promoter activity studies luciferase activity was normalized to
-galactosidase activity for each sample. Values in each group
were expressed relative to 360 mOsm controls. (B) The effect of
hyperosmotic loading on aggrecan promoter activity using PEG
and NaCl as osmolytes. Activity of pAGC1(−2368)/5UTR was
determined in response to 24 h of loading with various hyper-
osmotic media (580 mOsm). (C) Effect of hyperosmotic loading on
aggrecan mRNA levels. Total RNA was extracted from chondro-
cytes after 24 h of osmotic loading with 580 mOsm media
(sucrose). The mRNA copy number was calculated from each
sample and normalized to total RNA35. For each experiment, data
from each treatment group were expressed as a % of 360 mOsm.EFFECT OF RECOVERY FROM HYPER-OSMOTIC LOADING
To investigate if there is a correlation between osmotic
regulation of chondrocyte cell size and aggrecan gene
expression we determined cell size and aggrecan promoter
activity over a 24 h period of loading and then for a further
24 h recovery period. Recovery was performed by incubat-
ing cultured cells with control 360 mOsm media (DMEM)
following the 24 h period of hyperosmotic loading with
580 mOsm media. Chondrocyte cell size and aggrecan
Osteoarthritis and Cartilage Vol. 9, No. 8 765promoter activity were determined during hyperosmotic
loading and after the osmolality change (Fig. 4). As pre-
viously, chondrocyte cell size was not significantly
decreased until after 1 h of hyperosmotic loading
(P<0.0001, N=55) [Fig. 4(A)] with a 50% suppression,
relative to unloaded controls, in aggrecan promoter activity
observed after 5 h [Fig. 4(B), P<0.0001]. However, within
1 h of incubation with 360 mOsm media following hyperos-
motic loading chondrocytes recovered to within 5% of their
original size, P>0.05, N=25–55 [Fig. 4(A)]. Incubation with
360 mOsm media also affected aggrecan promoter activity.
Within 5 h, promoter activity was no longer suppressed
compared with unloaded controls and by 24 h activity was
48% higher than controls [Fig. 4(B), P<0.0001].
We further investigated the effects of cell swelling and
shrinkage by subjecting monolayer chondrocytes to
dynamic osmotic loading by alternating media osmolality
between 360 and 580 mOsm for repeated cycles (Fig. 5).
The osmotic loading protocols consisted of complete
solution changes every 10 minutes (360–580–360, etc.),
i.e. at a frequency of 0.0017 Hz. In control cultures
repeated additions of 360 mOsm were performed to
account for potential shear effects. Figure 5(A) depicts the
normalized cell size for 10 cells analysed in the same field
of view. Chondrocytes were found to shrink and re-swell in
response to intermittent loading at 580 and 360 mOsm,while no cell size changes were observed in 360 mOsm
controls. The cell size immediately before and after each
change in medium [indicated by arrows in Fig. 5(A)] was
significantly different (P<0.0002–0.013, N=10). Therefore
chondrocytes can regulate their size in response to
repeated cycles of hyperosmotic loading. In transfected
cultures, dynamic loading also stimulated aggrecan pro-
moter activity 20% over controls, whereas static or continu-
ous loading for the same period decreased promoter
activity 20% [Fig. 5(B), P<0.05].–100
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Fig. 4. Chondrocyte cell size (A) and aggrecan promoter activity (B) following removal of hyperosmotic loading. Chondrocytes were
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CHONDROCYTE CELL SIZE AND AGGRECAN GENE EXPRESSION
In order to further characterize the response of chondro-
cytes to osmotic loading we investigated the effect of the
presence of serum (10% FBS) in the media on chondrocyte
cell size and aggrecan gene expression. In contrast to
serum-free conditions, chondrocyte cell size decreased
more gradually when serum was present [Fig. 6(A)], and no
recovery was observed after 1 h. After 24 h, cell size had
significantly decreased the same extent as serum-free
cultures (approximately 14%), but the cell morphology was
more flattened and fibroblast-like compared to a spherical/
cuboidal appearance in DMEM (not shown). Serum also
766 G. D. Palmer et al.: Osmotic regulation of aggrecan gene expressionaffected osmotic regulation of aggrecan gene expression.
Loading with 580 mOsm media containing 10% FBS did
not reduce activity of pAGC1(−2368)/5UTR [Fig. 6(B)].
Similarly, FBS blocked the down-regulation of aggrecan
mRNA levels. In related studies to assess the contribution
of serum proteins in this response, experiments were
performed with DMEM supplemented with bovine serum
albumin, comprising the major protein component of
serum. Sucrose addition to DMEM plus 0.1% BSA
(580 mOsm) resulted in a decreasing trend of aggrecan
promoter activity that was significant at 24 h. The normal-
ized promoter activity at 1 h was 1.09±0.43 (N=5), for 5 h
0.908±0.27 and for 24 h 0.59±0.35 (P<0.0001). The cells
exhibited size changes similar in trend to that for DMEM.0
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Mechanical loading of cartilage imposes a number of
changes on the physical environment of a chondrocyte,
including alterations in ionic and osmotic composition.
Although the osmotic environment within cartilage duringloading has not been directly measured, it has been sug-
gested that changes in extracellular osmolality and ion
concentration are partly responsible for the fall in proteogly-
can synthesis rates in response to static compression23. To
learn more about chondrocyte response to osmotic loading
as well as mechanotransduction, we subjected isolated
chondrocytes to levels and durations of differential osmotic
loading that have previously been shown to affect chondro-
cyte morphology and biosynthetic activity5,22,24–27,37–39
and investigated the effects on cell size and aggrecan gene
expression.
In chondrocytes, the passive water flux across the mem-
brane occurs very rapidly38,40 and osmotic regulation
occurs slowly, indicating that chondrocytes behave as
perfect osmometers25,41. In the present study, chondrocyte
cell size was decreased in response to hyperosmotic
loading, but cells were significantly larger at 24 h than after
10 min, indicating that some volume recovery took place
(Fig. 2). Similar studies have shown that isolated chondro-
cytes do not effectively regulate their volumes after short-
term (1 h) hyperosmotic loading5,26, although recovery to
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B: 360 mOsm, ; 580 mOsm, .initial size has been reported after 24 h in isolated chondro-
cytes5, and after 80 min in cartilage explants27. The
specific event(s) that give rise to the observed transcrip-
tional changes to aggrecan gene expression observed after
24 h of hyperosmotic loading are unclear. Potential stimuli
that may contribute to this response include the initial
passive flux of water out of the cell (e.g., 0–10 min in
Fig. 2), the early successful regulatory volume increase
(RVI) efforts by the cells (e.g., 10 min to 1 h in Fig. 2), the
later unsuccessful efforts by the cells for RVI (e.g., 1–5 h in
Fig. 2), and the final new cell shrunken equilibrium (e.g.,
5–24 h, Fig. 2). The role of these different stimuli will be
elucidated in the future through the examination of different
loading durations, frequency and osmotic differential
magnitude.
Our initial efforts to vary the frequency of osmotic loading
by application of a cyclic osmotic loading applied at
0.0017 Hz revealed a minor stimulation of aggrecan pro-
moter activity, whereas static loading for the same period
suppressed promoter activity (Fig. 5). This result indicates
that exposure to a hyperosmotic environment may be
stimulatory to aggrecan gene expression when the osmotic
stimulus is applied intermittently. This osmotic stimulus may
be more physiologically relevant as chondrocytes are likelyto be subjected to cyclical changes in their osmotic environ-
ment in vivo. Several authors have noted differing
responses of chondrocytes following either cell shrinkage
or swelling with respect to volume regulation26,36, K+
channel activation29, and calcium mobilization37,39. It is
likely that successive cell swelling and shrinking induced by
dynamic loading will affect these cellular processes. How-
ever, the duration, magnitude and rate of the applied
osmotic stimulus are likely to be major factors, as they are
for other physical stimuli, in determining the overall effect
on chondrocyte biosynthetic activity.
Our studies also demonstrated that hyperosmotic load-
ing regulates aggrecan gene expression, as determined by
cell transfection studies with the aggrecan promoter con-
struct, pAGC1(−2368)/5UTR, and quantitation of aggrecan
mRNA levels (Fig. 3). These findings are consistent with
the suppression of proteoglycan synthesis rates observed
in isolated chondrocytes when media osmolality was raised
above 300 mOsm25. Furthermore, activity of a truncated
promoter construct containing an exon 1 deletion, leaving a
5′ flanking region of −2368 to +25, was not suppressed by
hyperosmotic loading [Fig. 3(A)]. Our findings suggest that
transcriptional regulation through specific gene sequences
may be a major mechanism through which chondrocyte
768 G. D. Palmer et al.: Osmotic regulation of aggrecan gene expressiongenes are regulated in response to osmotic changes. Prior
sequence analysis of the deleted region of exon 1 has
revealed the presence of potential osmotic responsive
elements53 (G. Palmer, unpublished data). These include
three putative SSREs, which are known to modulate tran-
scriptional activity in response to mechanical stimuli42, and
an STRE which modulates gene regulation in Saccharomy-
ces cerevisiae in response to osmotic shock43. Further
deletion analysis of exon 1 will identify the osmotic respon-
sive elements that modulate aggrecan gene expression in
response to hyperosmotic loading.
To further characterize the chondrocyte response to
osmotic loading we investigated the effect of restoring the
extracellular osmolality to physiological levels (DMEM)
after hyperosmotic loading (Fig. 4). Cell size recovered to
within 5% of initial size almost immediately and this was
accompanied by a slower rebound of aggrecan promoter
activity which was eventually elevated 50% above
unloaded controls after 24 h. This experiment could also be
viewed as a single cycle of a 1.2×10−5 Hz dynamic loading
stimulus. A ‘rebound’ of proteoglycan synthesis rates to
control levels has been observed within an 8–48 h period
following removal of static compressive loading in cartilage
disks13,14,44. The stimulation after 24 h observed in our
studies using isolated chondrocytes may be explained by
the lack of regulatory influences of the ECM. ECM deple-
tion in cultured chondrocytes has led to a stimulation of
proteoglycan synthesis45 and aggrecan mRNA expres-
sion46. Nevertheless the observed correlation between cell
size and aggrecan promoter activity suggests that osmotic
changes in cell morphology directly regulate expression of
the aggrecan gene. Several studies have demonstrated a
relationship between phenotypic expression and chondro-
cyte cell shape in cytoskeletal components rather than
actual cell-shape47–49. Osmotic shock of chondrocytes in
the range of 480–580 mOsm has been shown to alter
chromatin and cytoskeletal structure, as well as mor-
phology of the endoplasmic reticulum22. These intracellular
changes could potentially affect the transcriptional and
translational processes involved with aggrecan gene
expression.
There is evidence to suggest that the responses of cells
to mechanical stimuli are modulated by biological agonists
such as serum50–52. Since serum is often used in tissue
culture for in vitro cartilage and chondrocyte studies, we
investigated the effects of serum on the chondrocyte
response to osmotic loading. The presence of fetal bovine
serum blocked osmotic regulation of aggrecan gene
expression but did not affect cell shrinkage (Fig. 6). The
effect on gene expression is likely to be due to the action of
biochemical mediators (e.g. growth factors) in serum, since
replacement with albumin (0.1% BSA)—a major serum
protein—did not block osmotic regulation of aggrecan pro-
moter activity. As serum is also known to stimulate aggre-
can gene expression in cell culture53,54 (and unpublished
data) it is not clear whether its effect on aggrecan gene
expression in the present study is because of a masking
effect due to saturating levels of serum, or direct inhibition
of osmotic signaling mechanisms. We noted that a larger
proportion of cells appeared more fibroblast-like when
serum was present. Interestingly, a transition to a more
fibroblast-like phenotype has been observed in chondro-
cytes cultured in serum-containing hyperosmotic media
over a 2-week period22 although it has not been deter-
mined if this leads to changes in biosynthetic activity or
gene expression. The presence (and concentration) of
serum may therefore be an important factor in determiningthe chondrocyte response to osmotic loading and perhaps
other physicochemical stimuli. Our bovine serum albumin
result implies that chemical mediators (e.g. growth factors)
in serum are responsible for giving rise to the observed
disparate response with respect to serum-free cultures.
The present study on isolated cells has extended the
current understanding of how chondrocytes respond to
hyperosmotic loading. We report that hyperosmotic
loading-induced regulation of aggrecan gene expression in
chondrocytes is modulated through a specific region of the
gene. However, our findings suggest that the overall effect
on gene expression is determined by factors such as
the temporal nature of the loading and the presence of
potential biological agonists, i.e., serum. Our preliminary
studies55 of chondrocytes encapsulated in agarose28 sub-
jected to 24 h of hyperosmotic loading have demonstrated
aggrecan promoter activity results that parallel those
reported here, and provide evidence that our observations
are not due solely to the use of monolayer cultures.
Although this aggrecan response appears to be similar, it
remains to be determined if the same mechanisms (e.g.
cell size change, cytoskeletal reorganization) govern the
response under both culture conditions.Acknowledgments
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